checkAd
    Startseite > Aktien > bluebird bio > Nachrichten
    bluebird bio Aktie
    0,9794
     
    EUR
    -10,92 %
    -0,1201 EUR
    Letzter Kurs 10.05.24 Tradegate
    0,9652
     
    EUR
    3.108 STK
    Geldkurs 10.05.24
    0,9938
     
    EUR
    3.018 STK
    Briefkurs 10.05.24
    ISIN: US09609G1004 · WKN: A1W025 · SYM: BLE · USA

    Neueste Nachrichten

    bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
    09.05.24 · Business Wire (engl.) · bluebird bio
    bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events
    06.05.24 · Business Wire (engl.) · bluebird bio
    bluebird bio Announces Completion of First Cell Collection for LYFGENIA Gene Therapy
    06.05.24 · Business Wire (engl.) · bluebird bio
    bluebird bio Announces Receipt of Expected Notice from Nasdaq
    26.04.24 · Business Wire (engl.) · bluebird bio
    BLUE Shareholders with Significant Losses are Urged to Contact Robbins LLP to Discuss the bluebird bio, Inc. Class Action
    12.04.24 · Business Wire (engl.) · bluebird bio
    bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    11.04.24 · Business Wire (engl.) · bluebird bio
    BLUE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    09.04.24 · Business Wire (engl.) · bluebird bio
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE)
    03.04.24 · Business Wire (engl.) · bluebird bio
    bluebird bio, Inc. (BLUE) Stockholder Alert: Robbins LLP Reminds Investors of bluebird bio, Inc. Class Action
    02.04.24 · Business Wire (engl.) · bluebird bio
    Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE)
    02.04.24 · Business Wire (engl.) · bluebird bio
    The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of bluebird bio, Inc. (BLUE) Investors
    01.04.24 · Business Wire (engl.) · bluebird bio
    BLUE LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BLUE
    01.04.24 · Business Wire (engl.) · bluebird bio